banner

CLSA Events

Shire Partnering Day

Shire

Partnering Areas of Interest

CNS • GI • Orphan Diseases
Hematology • Platform Technologies

Shire, one of the world’s leading specialty biopharmaceutical companies, is fully focused on a single purpose: to enable people with life-altering conditions to lead better lives.

Through our Shire Human Genetic Therapies (HGT) business, we pursue opportunities on behalf of patients and families facing such rare diseases as Fabry disease, Hunter syndrome, Gaucher disease, hereditary angioedema, and metachromatic leukodystrophy—patients whose very lives often hinge on the discovery and delivery of extraordinary medicines. Through our Specialty Pharma business, meanwhile, we develop and distribute an innovative portfolio of treatments for patients with ADHD, ulcerative colitis, and end-stage renal disease. Our commitment throughout is on symptomatic diseases, treated by specialist physicians. We take the risks we need to take, so that we might change lives for the discernible better.

Why Partner with Shire?

Strategic partnerships have fueled Shire’s rapid growth—acquisitions and mergers designed to fortify development as well as marketed portfolios. Consequently all collaborative opportunities are managed in a rapid and responsible manner. To facilitate this, Shire’s business development team benefits from direct access to internal expertise across the full range of product development functions from initial scientific review through to full commercial evaluation.

To any prospective partner, Shire offers

  • A highly experienced executive management team, that importantly, for a company of Shire’s size and growth, retains a flexible and creative approach to collaborations
  • Experienced Sales and Marketing capabilities in the leading World markets, focused upon specialty physicians, patients, and payers
  • Proven product development and regulatory capabilities
  • Objective and rapid response to partnering opportunities
  • A results driven culture

Shire’s BD team welcomes approaches from organizations with products, technologies or projects that fit with our areas of interests.

Confirmed Shire Participants

Mindy Brooks, PhD
West Coast Scout/Consultant

Barbara Deptula
Executive Vice President and
Chief Corporate Development Officer

Jennifer King, Ph.D.
Senior Director, Scientific Licensing

Brian Piper
Senior Director, Strategic Investment Group

Greg Robinson, Ph.D.
Senior Director, Scientific Licensing

Jonathan Rubin, Ph.D., MBA
Scientific Licensing

Arthur Tzianabos
Vice President and Head of Research

What: Shire Partnering Day
When: Thursday, October 6, 2011
8:00am – 9:00am
Registration and Networking Breakfast
9:00am – 10:00am
Opening Plenary: Why Partner with Shire?
(open to employees of life science companies only)
10:30am – 4:30pm
One-on-One Partnering Meetings
(open to pre-qualified life science companies)
Where: Marriott San Mateo
1770 South Amphlett Boulevard
San Mateo, CA 94402
Conference Room: Engage on the lobby level
Parking: Valet or Self Parking On-site (fees apply)
Getting There: Public Transportation
Admission:

Breakfast Only
Free to Attend
Partnering
BayBio Members: Free | Non-Members: $500*
This event is open to employees of life science companies only.

Attire: Business attire suggested